article thumbnail

Leading pharmaceutical solid dose (commercial dose) manufacturing companies in contract marketing

Pharmaceutical Technology

Contract development and manufacturing organisations are increasingly becoming an important part of oral solid dose drug development and manufacturing process for many small, medium as well as large pharma companies.

article thumbnail

How Are Biopharma Companies Evaluating Partnerships in the Rare Disease Space?

Camargo

Thomas Kassberg, Chief Business Officer, Ultragenyx. The amount of interest and investment in rare diseases and orphan drugs has grown tremendously in recent years, leading to continuous innovation in a space that was once largely overlooked.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ferrer secures worldwide rights to PSP drug

Drug Discovery World

Spanish pharma company Ferrer and Swiss biotech Asceneuron have signed a licensing agreement giving Ferrer the rights to ASN90 in progressive supranuclear palsy (PSP), an orphan, tau-related disease with a high unmet medical need. ASN90 is a very promising addition to our growing portfolio in neurological disorders.”

Drugs 52
article thumbnail

Seqster launches new cloud version of virtual trial data tool

pharmaphorum

Healthcare technology firm Seqster has introduced a new version of its service that aims to help pharma companies work with patients’ data while on virtual clinical trials. Seqster announced the new version of its platform had been launched on the Microsoft Azure cloud at the annual JP Morgan Healthcare Conference. The new Seqster 7.1

Trials 52
article thumbnail

Merck confirms $11.5bn Acceleron takeover deal

pharmaphorum

.” It also said that “strategic business development” is a top priority for the company at the moment, reflecting a longstanding concern that it has become over-reliant on Keytruda and needs to diversify.

Sales 101
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Mark holds a PhD in biomedicine, and an MSc in biostatistics.

article thumbnail

The new technologies strengthening pharmaceutical supply chains

Pharmaceutical Technology

The legacy of this disruption has been a rethink in the way pharma companies do business. The pharma supply chain is emerging strongest and most sustainable where there is a high level of automation and digitalization. Visibility that’s not accessible in real time isn’t really visibility at all.

Big Data 130